Hypertrophic Cardiomyopathy: Novel Predictors of Outcome (CHRISTOPHER M. KRAMER, MD) March 22, 2018

Поделиться
HTML-код
  • Опубликовано: 3 авг 2024
  • “Hypertrophic Cardiomyopathy: Novel Predictors of Outcome”
    Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference featuring CHRISTOPHER M. KRAMER, MD as he discusses “Hypertrophic Cardiomyopathy: Novel Predictors of Outcome".
    Introduction & Moderator: WILLIAM A. ZOGHBI, MD
    Featured Speaker: CHRISTOPHER M. KRAMER, MD
    _______________________________________________________________
    HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER
    GRAND ROUNDS
    STATEMENT OF NEED
    This program is designed, in light of reviewing quality data retrieved from weekly evaluations, to provide physicians, faculty, fellows and residents access to topics in current basic and clinical research to improve patient care.
    TARGET AUDIENCE
    The target audience for this activity is: Cardiology and Cardiovascular Surgery Physicians, Fellows, Residents, NPs,
    PAs, Nurses, Radiologic Technologists, Sonographers and Research Coordinators.
    EDUCATIONAL OBJECTIVES
    At the conclusion of this activity, the participant should be able to:
    • Discuss updates on diagnosis, treatment and management of cardiovascular disease.
    • Integrate data and available technique in order to reach appropriate treatment decisions.
    • Describe research models, methods and statistical tools.

Комментарии • 3

  • @cordocshock
    @cordocshock 3 года назад

    one of your best.

  • @MsACButterfly
    @MsACButterfly 3 года назад

    WOW! It’s the first time I hear someone say there is ‘acquired’ HCM. I think I have this form of HCM instead of the genetic one. 👍👏❤️

  • @darkzeus28
    @darkzeus28 4 года назад

    Fabulous